Guidroz Allyson bought AMED
February 16, 2024 · Form 4 insider transaction
Guidroz Allyson bought 2,143 shares of Amedisys, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 81 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,143
Price
$0.00
Total value
N/A
InsiderGuidroz Allyson
Role—
CompanyAmedisys, Inc. (AMED)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 16, 2024
Filing dateMay 7, 2024
Shares owned after7,277
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1. The Issuer awarded the Reporting Person 2,143 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/4 installments on each of February 16, 2025, 2026, 2027 and 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.